Europe providing funding for cancer biomarkers; Melanoma biomarker assay to enter validation studies;

> OracleBio has signed an agreement with RedX Pharma for translational biomarker services for preclinical R&D. Release

> Canada's PROOF Centre has licensed the GVK Bio Online Clinical Biomarker Database to help develop biomarkers for heart, lung and kidney failure. Item

> BBVA Foundation is funding a Massachusetts General and Vall d'Hebrón Institute of Oncology collaboration over cancer biomarkers. Announcement

> DermTech's melanoma biomarker assay is set to enter validation studies. Press release

> Europe is providing funding for cancer biomarkers, helping to push forward personalized medicine. More

> MDxHealth says a prototype of its Prostate ConfirmMDx test can help urologists tell the difference between patients who have a true negative biopsy from those who may have cancer. The company plans to launch an epigenetics test in 2012. Press release

> Sera Prognostics has secured $19.3 million in a Series A round of funding to support the launch of biomarker-based preterm birth predictor. Press release

> Could apolipoprotein E be a biomarker for MCI? Abstract

And Finally... Researchers have created a mathematical model for ovarian cancer based on the biomarker CA125, which shows that tumors could exist for up to 10 years before being detectable by current blood tests. Item